16-1790445-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_004970.3(IGFALS):c.*155T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000706 in 705,068 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00056 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00075 ( 2 hom. )
Consequence
IGFALS
NM_004970.3 3_prime_UTR
NM_004970.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.393
Genes affected
IGFALS (HGNC:5468): (insulin like growth factor binding protein acid labile subunit) The protein encoded by this gene is a serum protein that binds insulin-like growth factors, increasing their half-life and their vascular localization. Production of the encoded protein, which contains twenty leucine-rich repeats, is stimulated by growth hormone. Defects in this gene are a cause of acid-labile subunit deficiency, which maifests itself in a delayed and slow puberty. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SPSB3 (HGNC:30629): (splA/ryanodine receptor domain and SOCS box containing 3) Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to be located in cytosol. Predicted to be part of SCF ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 16-1790445-A-C is Benign according to our data. Variant chr16-1790445-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 318228.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IGFALS | NM_004970.3 | c.*155T>G | 3_prime_UTR_variant | 2/2 | ENST00000215539.4 | ||
IGFALS | NM_001146006.2 | c.*155T>G | 3_prime_UTR_variant | 2/2 | |||
IGFALS | NR_027389.1 | n.2027T>G | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IGFALS | ENST00000215539.4 | c.*155T>G | 3_prime_UTR_variant | 2/2 | 1 | NM_004970.3 | P1 | ||
SPSB3 | ENST00000569769.1 | c.-13+3192T>G | intron_variant | 3 | |||||
IGFALS | ENST00000415638.3 | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000559 AC: 85AN: 152004Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
85
AN:
152004
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00109 AC: 137AN: 125704Hom.: 0 AF XY: 0.00107 AC XY: 73AN XY: 68530
GnomAD3 exomes
AF:
AC:
137
AN:
125704
Hom.:
AF XY:
AC XY:
73
AN XY:
68530
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000747 AC: 413AN: 553064Hom.: 2 Cov.: 6 AF XY: 0.000767 AC XY: 226AN XY: 294676
GnomAD4 exome
AF:
AC:
413
AN:
553064
Hom.:
Cov.:
6
AF XY:
AC XY:
226
AN XY:
294676
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000559 AC: 85AN: 152004Hom.: 1 Cov.: 33 AF XY: 0.000525 AC XY: 39AN XY: 74236
GnomAD4 genome
AF:
AC:
85
AN:
152004
Hom.:
Cov.:
33
AF XY:
AC XY:
39
AN XY:
74236
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Short stature due to primary acid-labile subunit deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at